New Insight: Phase 2 BEHOLD Study and UBX1325 for DME, Live at AAO 2023

Nov 05, 2023, 01:00 AM

On the floor at AAO 2023, host Veeral Sheth, MD, and producer Connor Iapoce discuss UBX1325 for patients with diabetic macular edema, based on the 48-week results from the phase 2 BEHOLD study.

Episode Highlights:
0:30 Introduction
0:48 Background into UBX1325 and BEHOLD
2:49 BEHOLD 48-week results
6:05 Next steps
6:56 Conclusion

Please direct any podcast-related inquiries to ciapoce@mjhlifesciences.com.